The inconsistencies regarding the UBR5 transcriptional data in the prediction of the CRC prognosis between the MVRM and TCGA cohorts might be attributed to the differences in the methods used to assess mRNA expression and unpredictable discrepancies in the follow-up of patients between the 2 cohorts. The gene discussed is UBR5; the disease is colorectal carcinoma.